Introduction
============

The composition of plasma membranes of virtually all eukaryotic cells is established, maintained, and remodeled by exocytosis, endocytosis, and a process of membrane recycling facilitated by endosomes. Cells are estimated to internalize their cell surface equivalent one to five times per hour (Steinman et al., [@B34]). This rapid removal of membrane from the cell surface is balanced by endosomal recycling pathways, which return most of the endocytosed proteins and lipids back to the plasma membrane (Maxfield and McGraw, [@B26]). Thus, a stringent regulation of recycling is essential to maintain the balance between endocytic uptake and recycling pathways. Disruptions in endocytosis and recycling are known to adversely affect diverse cellular processes (Yamamoto et al., [@B41]; Hryciw et al., [@B13]; Golachowska et al., [@B10]; Stendel et al., [@B35]).

Kidneys reabsorb \>95% of all proteins filtered through the glomerular apparatus (Nielsen, [@B30]). Proteinuria is one of the markers of renal dysfunction. Within the apical membranes of proximal tubule cells in the kidney, an extensive endocytic apparatus plays a key role in the reabsorption and degradation of glomerular-filtered albumin and other proteins (Marshansky et al., [@B24]) and in the recycling of many functionally important membrane transporters (Brown and Stow, [@B4]). We hypothesized that any alterations in endosomal recycling disrupts cellular homeostasis and thereby could affect renal function. The current study was designed to test whether altered endosomal recycling facilitated by a congenic segment previously mapped on rat chromosome 10 containing rififylin (Gopalakrishnan et al., [@B11]) can affect renal molecular and cellular physiology and thereby contribute to the extent of protein excretion in a rat model of cardiovascular and renal disease.

Materials and Methods
=====================

Animals
-------

All of the animal experiments were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and as per approved protocols by the institutional animal care and use review committee of the University of Toledo College of Medicine and Life Sciences. The congenic strain used in the current study was constructed in our laboratory using S and LEW rats. The strain is designated as S.LEW (10) × 12 × 2 × 3 × 5 and the construction of this congenic strain is detailed elsewhere (Gopalakrishnan et al., [@B11]).

cDNA analyses
-------------

mRNA from kidneys of neonates and 53 days old rats were extracted using TRIzol Reagent (Life Technologies). cDNA was obtained by reverse transcription with SuperScript III (Invitrogen) using an Oligo dT primer. Using genomic sequence data for rat *Rffl* gene available at the Ensembl website[^1^](#fn1){ref-type="fn"}, sense (5′CAGCTGAAGGAGATCCTGGC3′) and antisense (5′CCATGCAAATCTTACACAGGTTC3′) primers were designed to amplify exons 4--6 of the *Rffl* transcript by PCR. The resultant cDNA product was confirmed by sequencing using services provided by MWG Biotech Inc. DNA alignments were done using the sequence analysis software *Sequencher* from GeneCodes Corporation. Transcript expression of *Rffl* was analyzed by Real-Time PCR (BioRad) and expression levels relative to *Gapdh* were calculated by the 2^−ΔΔCT^ method (Livak and Schmittgen, [@B23]).

Immunoblot analyses
-------------------

Protein lysates were prepared as described previously (Gopalakrishnan et al., [@B11]) and subjected to Tricine/SDS-PAGE, transferred to PVDF membrane, incubated with specific primary antibodies followed by secondary antibodies and processed by ECL. Membranes were re-probed with monoclonal anti-Gapdh. The immunoblots were analyzed by densitometric scanning using Image J software. Sources of primary antibodies: Cell Signaling Technology (anti-Gapdh), Abcam (anti-Rffl), the Developmental studies hybridoma bank at the University of Iowa (monoclonal antibody against the Na^+^K^+^ATPase α-1 subunit, clone α6F), Santa Cruz Biotechnology (Donkey anti-rabbit IgG-HRP conjugate).

Early endosome isolation and western blot analysis of Na^+^K^+^ATPase α1 subunit
--------------------------------------------------------------------------------

Early endosome (EE) fractions (Eea-1 and Rab5 positive) were isolated from renal proximal tubules by sucrose flotation centrifugation as previously described (Liu et al., [@B21]). The enrichment of EE fractions was assessed by the EE marker Eea-1. Equal amount of total proteins (25 μg) from the EE fraction of each sample was precipitated with trichloroacetic acid for subsequent western blot analysis.

Whole genome transcriptional profiling
--------------------------------------

RNA was isolated from the kidneys of concomitantly raised, male, 53-day-old S, and congenic rats (*n* = 6 per group) using TRIzol and purified by RNeasy kit (Qiagen). RNA from two animals was pooled. Three such pooled RNA samples from S and congenic rats were hybridized to Affymetrix Rat Expression Arrays 230 2.0. The arrays were scanned at the Genomics core laboratory of the University of Toledo <http://www.utoledo.edu/med/depts/bioinfo/cores/genointro.html>. Statistical analyses of the microarray data were performed using the R statistical package (version 2.8.1). The microarray data are in compliance with the Minimum Information About Microarray Experiments and were uploaded into the Gene Expression Omnibus database[^2^](#fn2){ref-type="fn"}. Pathway analysis was conducted using Ingenuity Systems Pathway Analysis[^3^](#fn3){ref-type="fn"}.

Isolation and primary culture of rat proximal tubule cells
----------------------------------------------------------

Primary rat proximal tubule (RPT) cells were isolated from cortices of rat kidneys from S and congenic rats as described previously (Liu et al., [@B21]).

Labeling of cell surface Na/K-ATPase by biotinylation
-----------------------------------------------------

Cell surface biotinylation of Na/K-ATPase in proximal tubule primary cultures was performed as previously described (Liu et al., [@B20], [@B19], [@B21]). After surface biotinylation with EZ-Link sulfo-NHS-ss-Biotin (Pierce) and immobilization with ImmunoPure immobilized streptavidin-agarose beads (Pierce), biotinylated proteins were eluted after incubation in a 55°C water bath for 30 min, mixed with an equal volume of 2× Laemmli sample buffer, resolved by 10% SDS-PAGE, and then immunoblotted.

Transferrin recycling
---------------------

Transferrin recycling was studied as described previously (Gopalakrishnan et al., [@B11]). In brief, isolated proximal tubules were maintained at 37°C with 5% CO~2~ and allowed to internalize a fluorescent derivative of transferrin (Alexa^488^-Tf, Molecular Probes) for 90 min at 37°C and washed three times with ice cold PBS. Recycling was induced by warming the cells to 37°C in a serum free medium containing 0.1% BSA and a 100-fold excess of unlabelled holotransferrin (Sigma) and monitored by live imaging using a Leica TCS SP5 laser scanning confocal microscope. Just before monitoring, DRAQ5 was added to visualize the nuclei. Cells were imaged using a 488 and 433 laser line in the *XY* plane with scanning set at 30 s intervals for 30 min. Paired time lapse studies were performed in triplicate using the same gain, offset, and laser power settings to ensure that there were no intensity differences due to the acquisition settings between S and Congenic. Mean fluorescent intensity was measured in Image J at individual time points of the acquired images.

Polyubiquitinated proteins
--------------------------

Polyubiquitin-modified proteins were isolated from kidneys using the Pierce Ubiquitin Enrichment Kit as per previously published procedures (Gopalakrishnan et al., [@B11]).

Urinary protein excretion
-------------------------

Urinary Protein Excretion (UPE) determination was done as previously described (Kumarasamy et al., [@B17]). Briefly, at 53 days of age, rats fed with low salt (0.3% NaCl) was housed individually in metabolic cages and urine was collected over a 24-h period. Urinalysis was conducted using services provided by the University of Toledo Medical Center. The pyrogallol based QuanTtest Red Total Protein Assay from Quantimetrix (Redondo Beach, CA, USA) was used to determine protein concentrations of the urine samples. A VERSAmax microplate reader from Molecular Devices (Sunnyvale, CA, USA) was used to determine absorbance at 600 nm. Protein concentrations were determined by reading against the absorbance of the QuanTtest human protein standards (25--200 mg/dL). UPE data is presented as mg/mg creatinine over a 24-h period.

Statistical analyses
--------------------

All phenotypic data obtained from the two groups (congenic and S rats) were statistically analyzed by Student *t*-test. A *p*-value of \<0.05 was considered statistically significant. Statistical analyses of the microarray data were performed with robust multiarray averaging and Benjamini and Hochberg adjustment using the R statistical package (version 2.8.1).

Results
=======

The rat strains chosen as tools for this study were the Dahl S rat and *a* \> 99% genetically identical strain, the S.LEW congenic strain, which has *a* \< 330 kb of the LEW rat genome introgressed onto the genome of the S rat (Figure [1](#F1){ref-type="fig"}A). At 52 days of age, the systolic blood pressure of the congenic strain measured by the telemetry method was 138 ± 2 mmHg compared with that of the S, 132 ± 2 mmHg, *p* \< 0.01 (Gopalakrishnan et al., [@B11]). The introgressed segment contained the gene rififylin, overexpression of which is known to cause a delay in endosomal recycling in cardiomyocytes (Gopalakrishnan et al., [@B11]). Rififylin was also transcribed in the kidneys of both the S and the congenic strain (Figure [1](#F1){ref-type="fig"}B), however, kidneys of congenic rats had a 1.56-fold higher mRNA of rififylin compared with that of the S (*p* \< 0.001; Figure [1](#F1){ref-type="fig"}C). Protein levels of rififylin were also higher both in the kidney and within the proximal tubules of congenic rats compared with S (Figures [1](#F1){ref-type="fig"}D,E).

![**(A)** Schematic diagram of the congenic strain used in the study. The \<330 kb region spanned by the congenic strain S.LEW (10) × 12 × 2 × 3 × 5 is shown alongside the physical map of rat chromosome 10. The basepairs delineating the ends of the congenic segment and the gene annotations were obtained from [Ensembl.org](Ensembl.org). (RGSC 3.4) RNO10, Rat chromosome 10; Mb, Megabases. **(B)** Expression of *Rffl* transcript in the kidneys at 53 days of age as detected by RT-PCR. **(C)** Quantification of *Rffl* transcripts relative to S rats by real-time PCR using whole kidney samples from 53-day-old rats (*n* = 6 animals per group). Immunoblot of Rffl in **(D)** whole-cell lysates from S (*n* = 3) and congenic (*n* = 3) rat kidneys at 53 days of age; **(E)** proximal tubules from S (*n* = 3) and congenic (*n* = 3). RFFL (NP_0010717368, 2aa-99aa, 36.41 kDa) partial recombinant protein was used as positive control and Gapdh was the loading control. Quantification of Rffl protein ± SEM is shown alongside.](fgene-03-00138-g001){#F1}

To study the alterations in the renal transcriptome between the S and the congenic strain with increased expression of rififylin, a whole genome renal transcriptome analysis was conducted. A total of 1082 probes representing 838 genes and 244 ESTs were upregulated in the congenic strain compared with S. Similarly, a total of 785 probes representing 423 genes and 362 ESTs were down-regulated in the congenic strain compared with S (GSE30770). Among these transcripts, the highest differential expression of 5.33-fold was observed with *Atp1a1*, which was upregulated in the congenic strain compared with S (Table [A1](#TA1){ref-type="table"} in Appendix). Notably, a number of transcripts coding for proteins either directly or indirectly related to the sorting of endosomes were upregulated in the congenic strain compared with S. The relative changes in gene expression of differentially expressed genes are in Table [1](#T1){ref-type="table"}. The networks of these gene products that facilitate clathrin-coated membrane invagination and endocytosis are depicted in Figure [2](#F2){ref-type="fig"}. The other genes differentially expressed belonged to two prominent networks related to cellular morphology and renal associated function (Figures [3](#F3){ref-type="fig"}A,B). While *Atp1a1* featured in the network represented in Figure [3](#F3){ref-type="fig"}A, several transcripts coding for Rab proteins including *Rab5* which regulates transport from plasma membrane to EEs and *Rab11* involved in endocytic recycling (Trischler et al., [@B39]) featured in the network represented in Figure [3](#F3){ref-type="fig"}B. The fold changes of all the transcripts within these two additional networks are given in the Table [A1](#TA1){ref-type="table"} in Appendix.

###### 

**Differentially expressed transcripts in the clathrin-mediated endocytosis network**.

  Affymetrix ID   Fold change   *p*-Value   Symbol      Entrez gene name
  --------------- ------------- ----------- ----------- -------------------------------------------------------------
  1369733_at      2.201         0.0258      *Ctnnb1*    Catenin (cadherin-associated protein), beta 1, 88 kDa
  1393288_at      1.897         0.0366      *Rab5b*     RAB5B, member RAS oncogene family
  1398825_at      1.802         0.0434      *Rab11b*    RAB11B, member RAS oncogene family
  1371113_a\_at   1.787         0.0411      *Tfrc*      Transferrin receptor (p90, CD71)
  1368762_at      1.749         0.0232      *Ubd*       Ubiquitin D
  1399153_at      1.715         0.0356      *Rab5b*     RAB5B, member RAS oncogene family
  1369998_at      1.708         0.0268      *Arf6*      ADP-ribosylation factor 6
  1372513_at      1.63          0.0268      *Rac1*      Ras-related C3 botulinum toxin substrate 1
  1388022_a\_at   1.459         0.018       *Dnm1l*     Dynamin 1-like
  1388104_at      1.436         0.0225      *Igr4*      Leucine-rich repeat containing G protein-coupled receptor 4
  1370672_a\_at   1.416         0.0422      *Dnm3*      Dynamin 3
  1374232_at      1.416         0.0166      *Pik3ca*    Phosphoinositide-3-kinase, catalytic, alpha polypeptide
  1384101_at      1.414         0.0362      *Wasl*      Wiskott--Aldrich syndrome-like
  1370081_a\_at   1.409         0.0236      *Vegfa*     Vascular endothelial growth factor A
  1384750_at      1.392         0.037       *Numb*      Numb homolog (*Drosophila*)
  1395548_at      1.378         0.0331      *Eps15*     Epidermal growth factor receptor pathway substrate 15
  1392643_at      1.355         0.0355      *Rab5b*     RAB5B, member RAS oncogene family
  1387170_at      1.238         0.0473      *Csnk2a1*   Casein kinase 2, alpha 1 polypeptide
  1368096_at      -1.291        0.0321      *Rab7l1*    RAB7, member RAS oncogene family like 1

Statistical analyses of the microarray data were performed with RMA, robust multiarray averaging; BH, Benjamini and Hochberg adjustment using the R statistical package (version 2.8.1). The complete microarray data is available to the reviewers at the following link: <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=hryjdweamuioidi&acc=GSE30770>

![**Illustration of the IPA network analysis of the differentially expressed transcripts associated with Clathrin-mediated endocytosis and recycling**. Transcripts shown in red were upregulated and green were down-regulated in the congenic strain compared with S. The fold changes of the corresponding Affymetrix probes are given in Table [1](#T1){ref-type="table"}.](fgene-03-00138-g002){#F2}

![**Illustration of the IPA networks of transcripts associated with cell morphology and renal function**. **(A)** network 1 with *Atp1a1* and **(B)** network with *Rab* proteins Transcripts shown in red were upregulated and transcripts shown in green were down-regulated in the congenic strain compared with S. The fold changes of the corresponding Affymetrix probes are given in Table [A1](#TA1){ref-type="table"} in Appendix.](fgene-03-00138-g003){#F3}

Next, we assessed the content of the protein product of the most differentially expressed gene, *Atp1a1*. Within the proximal tubules, the total protein content of the alpha subunit of Na^+^K^+^ATPase (referred to hereafter as alpha 1) was not different between S and the congenic strain (data not shown). Protein levels of alpha 1 were not different between the early endosomal fractions isolated from the proximal tubules of the congenic strain and the S (data not shown). However, surface biotinylation experiments indicated that the content of alpha 1 was notably higher on the cell membranes from the congenic strain compared with S (Figure [4](#F4){ref-type="fig"}). Total polyubiquitinated proteins were also significantly higher in the congenic strain compared with S (Figure [5](#F5){ref-type="fig"}).

![**Quantitation of the α-1 subunit of Na^+^K^+^ATPase on the plasma membranes of cells from proximal tubules (*n* = 3 animals per group)**. The surface biotinylation experiment on isolated proximal tubules was conducted as described under methods. The top panel of the western blot was probed with antibodies to the α-1 subunit of Na^+^K^+^ATPase. The bottom panel was probed with antibodies to β-actin. Densitometric scans are shown on the right hand side.](fgene-03-00138-g004){#F4}

![**Polyubiquitination of proteins**. **(A)** Immunoblot of polyubiquitinated proteins in whole-cell lysates from S (*n* = 3) and congenic (*n* = 3) rat kidneys. Control is from the Pierce ubiquitination kit. **(B)** Quantification of the blot shown in **(A)** by densitometry.](fgene-03-00138-g005){#F5}

To assess the extent of endosomal recycling in the kidney of the congenic strain with increased expression of *Rffl*, recycling of fluorescently labeled transferrin was monitored in individual proximal tubules. As shown in Figures [6](#F6){ref-type="fig"}A,B, recycling of transferrin was significantly delayed in the congenic strain compared with S.

![**Defective transferrin recycling in the proximal tubules from the congenic rats**. **(A)** The disappearance of fluorescently labeled transferrin was plotted using the initial mean intensity of labeled internalized transferrin (±SEM) by the proximal tubules taken as 100% in three independent experiments (*n* = 3 animals per group) conducted in duplicates (\*\**p* \< 0.01; \**p* \< 0.05). **(B)** Representative images, green -- fluorescently labeled transferring, blue -- DRAQ staining of nuclei.](fgene-03-00138-g006){#F6}

These observations, coupled with the fact that rififylin residing within the congenic segment is a regulator of cellular protein recycling, suggested that the primary delay in recycling of endosomes caused membrane proteins to accumulate intracellularly within the proximal tubules from the congenic strain. Because similar defects in membrane traffic and enhanced degradation of proteins are known to cause proteinuria (Marshansky et al., [@B24]), we tested the urine composition of the two rat strains at a very young age of 53 days. The total protein excretion was significantly higher by 31% in the congenic strain (11.91 ± 1.12 mg/mg creatinine/day) compared to that in the S (8.26 ± 1.08 mg/mg creatinine/day, *p* = 0.016; Figure [7](#F7){ref-type="fig"}). The other urinary parameters analyzed, i.e., urea nitrogen, glucose, and creatinine excretion were not significantly different between the S and the congenic strain (data not shown).

![**Urinary protein excretion in S and congenic rats**. Twenty-four hours urine samples were collected from S (*n* = 13) and congenic (*n* = 12) rats and total protein was quantitated. UPE data is presented as mg/mg creatinine over a 24-h period.](fgene-03-00138-g007){#F7}

Discussion
==========

Hypertension in the Dahl S rat is accompanied with proteinuria (Sustarsic et al., [@B38]; Sterzel et al., [@B37]; Garrett et al., [@B7]). Compared to the S rat, both blood pressure (Gopalakrishnan et al., [@B11]) and UPE are further increased in the congenic strain reported in the current study. We have previously demonstrated that overexpression of rififylin in the neonatal cardiomyocytes of this congenic strain is linked to short QT-interval and hypertension (Gopalakrishnan et al., [@B11]). While alterations in QT-interval can contribute to the development of hypertension (Baumert et al., [@B3]), it does not independently explain the observed increase in UPE of the congenic strain. Because rififylin is also reported to be expressed in other tissues (Coumailleau et al., [@B6]), we suspected that the fundamental cellular mechanism altered by the overexpression of rififylin could be operational in the kidney wherein rififylin is expressed at higher levels in the congenic strain compared with S. The present study provides evidence to suggest that upregulation of rififylin in the congenic strain compared with S is not limited to the heart, but is also observed at least in one additional organ, the kidney. Functional analysis of rififylin revealed that endocytic recycling is delayed within the proximal tubules. The renal transcriptome signature is reminiscent of perturbations in the endosomal sorting and transport pathways, alterations in which are reported to lead to proteinuria (Nielsen, [@B31]; Nielsen and Christensen, [@B29]).

Several structural proteins and GTPase regulators are indispensable for recycling endosomes (Grant and Donaldson, [@B12]; Schweitzer et al., [@B33]). Rififylin, also known as Carp-2, is a recent addition to the growing list of proteins associated with the cellular recycling machinery. Coumailleau et al. ([@B6]) described that overexpression of rififylin represents a novel means to inhibit recycling. Using deletion mutants, they demonstrated that the amino-terminal region of rififylin is critical for the recruitment of Rffl to recycling endocytic membranes and for the inhibition of recycling. The current study of delayed recycling in proximal tubules caused by increased renal expression of *Rffl* along with a previous similar report on cardiomyocytes from our group (Gopalakrishnan et al., [@B11]) represent the first two *in vivo* validations of the *in vitro* studies on HeLa cells reported by Coumailleau et al. ([@B6]).

Transcriptome profiling demonstrates that there are numerous changes in gene transcript levels in the kidneys of S versus the congenic strain. According to the IPA network analysis, genes upregulated were in networks including cellular assembly and organization, cellular function and maintenance and cell morphology, all of which are processes known to involve endocytic recycling (Schweitzer et al., [@B33]). Two lines of evidence further point to impaired endocytic recycling: (1) upregulation of transcripts in the clathrin-mediated endocytosis and recycling pathways and (2) delayed recycling of transferrin.

Additionally, Coumailleau et al. ([@B6]) have reported that rififylin *per se* does not affect endocytosis. Therefore any alteration in endocytosis is perhaps a representation of the concerted cellular feedback response to the primary defect in recycling in order to maintain cellular homeostasis.

A defect in recycling should either demonstrate an increased accumulation of cargo within the endosomes or trigger degradation of proteins. Evidence from increased polyubiquitinated proteins within the proximal tubules of the congenic strain compared with S point to the latter, i.e., upregulation of the cellular degradation machinery. This is not surprising because rififylin is also a known E3 ubiquitin ligase and we have previously demonstrated similar increased cellular polyubiquitination of proteins within the cardiomyocytes of the congenic strain used in the current study compared with S (Gopalakrishnan et al., [@B11]). Increased accumulation of polyubiquitination leads to cellular stress, which is known to adversely affect proteinuria (Meyer-Schwesinger et al., [@B27]). Therefore, it is possible that the increased accumulation of polyubiquitinated proteins in the congenic strain relative to the S, atleast in part, contributes to the observed increased in proteinuria of the congenic strain.

The increase in blood pressure of this strain has been previously attributed partly to increased heart rate observed in the congenic strain (Gopalakrishnan et al., [@B11]). The current study indicates that an additional factor contributing to the increased blood pressure of the congenic strain could be due to the compensatory mechanism of increased transcription and availability of the Na^+^K^+^ATPase at the surface of cells within the proximal tubules, which may cause increased sodium retention and thereby increase blood pressure.

Overall, three main reasons lead us to conclude that overexpression of rififylin within the congenic strain compared with S is a contributor to the observed alterations in kidney function as noted by alterations in proteinuria -- (1) the two strains compared were genetically identical except for the very short \<330 kb congenic segment harboring rififylin; (2) two known functional consequences of delayed endocytic recycling and accumulation of polyubiquitinated proteins (Coumailleau et al., [@B6], [@B5]) as a result of overexpression of rififylin were recapitulated in the congenic strain; and (3) *Rffl* is a candidate gene within the congenic interval that is reported to affect both recycling and polyubiquitination. Despite these compelling arguments, it remains to be determined using future mapping studies to further dissect the \<330 kb congenic segment as to whether additional factors within the congenic interval also contribute to the reported phenotypes.

Given that alpha1 is not within the congenic segment, it is also reasonable to conclude that the primary physiological perturbations that may have lead to the observed increase in transcription of alpha1 and the increased alpha 1 content on the plasma membrane is a compensatory mechanism. Of course, we would expect increased blood pressure as one of the consequences to this compensatory mechanism and the congenic strain indeed has higher blood pressure at a very young age of 52 days. Further, a prolonged cellular stress as a result of accumulation of excess proteins marked for degradation could be viewed as being highly detrimental because the congenic strain is reported to have a decreased life span compared with S (Gopalakrishnan et al., [@B11]).

Genome-wide association and linkage studies in humans and model organisms point to a number of candidate genes for chronic renal disease and/or albuminuria (Liu and Freedman, [@B22]; Krolewski et al., [@B16]; Turner et al., [@B40]; Arar et al., [@B1], [@B2]; Garrett et al., [@B8], [@B9]; Hwang et al., [@B14]; Iyengar et al., [@B15]; Leon et al., [@B18]; Martinez et al., [@B25]; Sterken and Kiryluk, [@B36]). The genome-wide association studies in particular only represent \<1.5% of the total variance in albuminuria observed in human populations. Therefore a large number of loci causing or contributing to renal function disorders in humans remain unidentified. Genome-wide studies have identified single nucleotide polymorphisms around the gene coding for rififylin in humans to QT-intervals (Newton-Cheh et al., [@B28]; Pfeufer et al., [@B32]), but not to any renal phenotypes. Through the discovery of a link between endosomal recycling, enhanced degradation, and a resultant altered trafficking of proteins within the proximal tubules, the present study provides the basis for evaluating rififylin as a novel candidate gene for renal disease characterized by proteinuria in humans.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

This work was supported by RO1 grants (HL020176, HL076709) to Bina Joe from the National Heart Lung and Blood Institute of the National Institutes of Health, Bethesda, USA.

^1^[www.ensembl.org](www.ensembl.org)

^2^<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=hryjdweamuioidi&acc=GSE30770>

^3^[www.ingenuity.com](www.ingenuity.com)

###### 

**Differentially expressed transcripts in networks (Figures [3](#F3){ref-type="fig"}A,B)**.

  Affymetrix ID               Fold change   *p*-Value   Symbol          Entrez gene name
  --------------------------- ------------- ----------- --------------- ------------------------------------------------------------------------------
  1371108_a\_at               5.3380        0.0334      Atp1a1          ATPase, Na^+^/K^+^ transporting, alpha 1 polypeptide
  1380533_at                  4.2845        0.0180      App             Amyloid beta (A4) precursor protein
  1369152_at                  3.3827        0.0319      Ppp3r1          Protein phosphatase 3, regulatory subunit B, alpha
  1368948_at                  3.1624        0.0383      Msn             Moesin
  1370503_s\_at               2.9373        0.0422      Epb41l3         Erythrocyte membrane protein band 4.1-like 3
  1390525_a\_at               2.7414        0.0397      Stra6           Stimulated by retinoic acid gene 6 homolog (mouse)
  1378015_at                  2.6839        0.0206      Ccl21           Chemokine (C--C motif) ligand 21
  1388774_at                  2.6075        0.0051      Mbd2            Methyl-cpg binding domain protein 2
  1383899_at                  2.5886        0.0335      Nedd4           Neural precursor cell expressed, developmentally down-regulated 4
  1395886_at                  2.5617        0.0327      Actr3           ARP3 actin-related protein 3 homolog (yeast)
  1387402_at                  2.5213        0.0303      Myh9            Myosin, heavy chain 9, non-muscle
  AFFX_Rat_beta-actin_5\_at   2.4164        0.0236      Actb            Actin, beta
  1386981_at                  2.4077        0.0157      Slc16a1         Solute carrier family 16, member 1 (monocarboxylic acid transporter 1)
  1382616_at                  2.3050        0.0359      Gls             Glutaminase
  1369733_at                  2.2009        0.0258      Ctnnb1          Catenin (cadherin-associated protein), beta 1, 88 kDa
  1370288_a\_at               2.1568        0.0201      Tpm1            Tropomyosin 1 (alpha)
  1369278_at                  2.1499        0.0202      Gna12           Guanine nucleotide binding protein (G protein) alpha 12
  1398822_at                  2.0847        0.0284      Gdi2            GDP dissociation inhibitor 2
  1369227_at                  2.0708        0.0137      Chm             Choroideremia (Rab escort protein 1)
  1392406_at                  2.0290        0.0370      Ipp             Intracisternal A particle-promoted polypeptide
  1370789_a\_at               2.0256        0.0435      Prlr            Prolactin receptor
  1369312_a\_at               2.0143        0.0280      Csnk1a1         Casein kinase 1, alpha 1
  1371028_at                  2.0125        0.0372      Tgoln2          Trans-golgi network protein 2
  1371139_at                  2.0094        0.0475      Pls3            Plastin 3
  1387810_at                  2.0016        0.0177      Keap1           Kelch-like ECH-associated protein 1
  1396267_at                  1.9907        0.0392      Pak2            p21 protein (Cdc42/Rac)-activated kinase 2
  1368537_at                  1.9863        0.0225      Dctn4           Dynactin 4 (p62)
  1383263_at                  1.9628        0.0177      Ogn             Osteoglycin
  1387392_at                  1.9581        0.0276      Mllt4           Myeloid/lymphoid or mixed-lineage leukemia; translocated to, 4
  1369779_at                  1.9506        0.0099      Myo1d           Myosin ID
  1375137_at                  1.9173        0.0366      Arpc2           Actin-related protein 2/3 complex, subunit 2, 34 kDa
  1379452_at                  1.9090        0.0372      Gas2            Growth arrest-specific 2
  1371239_s\_at               1.9033        0.0379      Tpm3            Tropomyosin 3, gamma
  1393288_at                  1.8966        0.0366      Rab5b           RAB5B, member RAS oncogene family
  1370141_at                  1.8715        0.0280      Mcl1            Myeloid cell leukemia sequence 1 (BCL2-related)
  1394965_at                  1.8507        0.0450      Clint1          Clathrin interactor 1
  1387952_a\_at               1.8175        0.0221      Cd44            CD44 molecule (Indian blood group)
  1398825_at                  1.8017        0.0434      Rab11b          RAB11B, member RAS oncogene family
  1397697_at                  1.7912        0.0321      Eif4a2          Eukaryotic translation initiation factor 4A2
  1371113_a\_at               1.7874        0.0411      Tfrc            Transferrin receptor (p90, CD71)
  1367651_at                  1.7835        0.0464      Ctsd            Cathepsin D
  1398311_a\_at               1.7425        0.0411      Kidins220       Kinase [d]{.smallcaps}-interacting substrate, 220 kDa
  1369197_at                  1.7379        0.0268      Apaf1           Apoptotic peptidase activating factor 1
  1368808_at                  1.7327        0.0282      Cap1            CAP, adenylate cyclase-associated protein 1 (yeast)
  1368838_at                  1.7273        0.0388      Tpm4            Tropomyosin 4
  1396214_at                  1.7272        0.0205      Kitlg           KIT ligand
  1369319_at                  1.7265        0.0333      Arl6ip5         ADP-ribosylation-like factor 6 interacting protein 5
  1388251_at                  1.7156        0.0368      Prkci           Protein kinase C, iota
  1396072_at                  1.6782        0.0364      Appbp2          Amyloid beta precursor protein (cytoplasmic tail) binding protein 2
  1382878_at                  1.6562        0.0224      Sfrp1           Secreted frizzled-related protein 1
  1391543_at                  1.6489        0.0266      Ripk1           Receptor (TNFRSF)-interacting serine-threonine kinase 1
  1382615_at                  1.6466        0.0460      Sec61a1         Sec61 alpha 1 subunit (*S. cerevisiae*)
  1397843_at                  1.6417        0.0473      Wdr44           WD repeat domain 44
  1370662_a\_at               1.6351        0.0421      Ap2b1           Adaptor-related protein complex 2, beta 1 subunit
  1369720_at                  1.6345        0.0257      Myo1b           Myosin IB
  1377769_at                  1.6329        0.0402      Ap1s1           Adaptor-related protein complex 1, sigma 1 subunit
  1372513_at                  1.6297        0.0268      Rac1            Ras-related C3 botulinum toxin substrate 1
  1387844_at                  1.6240        0.0175      Lasp1           LIM and SH3 protein 1
  1396250_at                  1.6206        0.0311      Coro1c          Coronin, actin binding protein, 1C
  1368832_at                  1.6121        0.0337      Akt2            v-akt murine thymoma viral oncogene homolog 2
  1369557_at                  1.6047        0.0093      Casp7           Caspase 7, apoptosis-related cysteine peptidase
  1393795_at                  1.5994        0.0392      Zeb2            Zinc finger E-box binding homeobox 2
  1368821_at                  1.5950        0.0180      Fstl1           Follistatin-like 1
  1383827_at                  1.5947        0.0439      Tlk1            Tousled-like kinase 1
  1378816_a\_at               1.5832        0.0221      osbp            Oxysterol binding protein
  1369234_at                  1.5818        0.0282      Slc20a2         Solute carrier family 20 (phosphate transporter), member 2
  1368395_at                  1.5704        0.0307      Gpc3            Glypican 3
  1388230_at                  1.5600        0.0327      Jub             Jub, ajuba homolog (*Xenopus laevis*)
  1370266_at                  1.5554        0.0327      Parva           Parvin, alpha
  1395132_at                  1.5543        0.0221      Utrn            Utrophin
  1367974_at                  1.5493        0.0342      Anxa3           Annexin A3
  1387420_at                  1.5445        0.0202      Clic4           Chloride intracellular channel 4
  1387690_at                  1.5417        0.0180      Casp3           Caspase 3, apoptosis-related cysteine peptidase
  1397200_at                  1.5319        0.0277      Chd4            Chromodomain helicase DNA binding protein 4
  1390706_at                  1.5289        0.0323      Sptbn1          Spectrin, beta, non-erythrocytic 1
  AFFX_Rat_Hexokinase_3\_at   1.5278        0.0388      Hk1             Hexokinase 1
  1370599_a\_at               1.5255        0.0292      Ptprs           Protein tyrosine phosphatase, receptor type, S
  1388762_at                  1.5226        0.0374      Iqgap1          IQ motif containing GTPase activating protein 1
  1369248_a\_at               1.5212        0.0442      Xiap            X-linked inhibitor of apoptosis
  1367939_at                  1.5168        0.0362      Rbp1            Retinol binding protein 1, cellular
  1384938_at                  1.5126        0.0470      Arhgap1         Rho GTPase activating protein 1
  1369879_a\_at               1.4963        0.0208      Tmbim6          Transmembrane BAX inhibitor motif containing 6
  1378287_at                  1.4835        0.0421      Rdx             Radixin
  1371127_at                  1.4768        0.0137      Bmp1            Bone morphogenetic protein 1
  1371056_at                  1.4595        0.0335      Neo1            Neogenin 1
  1378842_at                  1.4550        0.0465      Gabarapl1       GABA(A) receptor-associated protein like 1
  1379889_at                  1.4488        0.0321      Lamc2           Laminin, gamma 2
  1367891_a\_at               1.4455        0.0175      Casp2           Caspase 2, apoptosis-related cysteine peptidase
  1396742_at                  1.4423        0.0137      Ipo5            Importin 5
  1388557_at                  1.4420        0.0404      Tubb2c          Tubulin, beta 2C
  1367981_at                  1.4338        0.0436      Rabep1          Rabaptin, RAB GTPase binding effector protein 1
  1393055_at                  1.4328        0.0399      Pkn2            Protein kinase N2
  1369085_s\_at               1.4298        0.0323      Snrpn           Small nuclear ribonucleoprotein polypeptide N
  1371103_at                  1.4287        0.0268      Rab6a           RAB6A, member RAS oncogene family
  1384005_at                  1.4212        0.0355      Dr1             Down-regulator of transcription 1, TBP-binding (negative cofactor 2)
  1394077_at                  1.4202        0.0337      Rnd3            Rho family GTPase 3
  1370130_at                  1.4201        0.0393      Rhoa            Ras homolog gene family, member A
  1379345_at                  1.4034        0.0457      Col15a1         Collagen, type XV, alpha 1
  1373473_a\_at               1.3975        0.0307      Nap1l1          Nucleosome assembly protein 1-like 1
  1375538_at                  1.3927        0.0399      Vcl             Vinculin
  1384187_at                  1.3826        0.0287      Ap1s2           Adaptor-related protein complex 1, sigma 2 subunit
  1369816_at                  1.3815        0.0369      Rab3a           RAB3A, member RAS oncogene family
  1368218_at                  1.3797        0.0424      Ralbp1          ralA binding protein 1
  1395548_at                  1.3777        0.0331      Eps15           Epidermal growth factor receptor pathway substrate 15
  1385797_at                  1.3757        0.0377      Actc1           Actin, alpha, cardiac muscle 1
  1382402_at                  1.3687        0.0321      Ulk1            Unc-51-like kinase 1 (*C. elegans*)
  1371059_at                  1.3669        0.0302      Prkar2a         Protein kinase, cAMP-dependent, regulatory, type II, alpha
  1383531_at                  1.3571        0.0342      C5orf41         Chromosome 5 open reading frame 41
  1381509_at                  1.3482        0.0341      Nbr1            Neighbor of BRCA1 gene 1
  1383701_at                  1.3470        0.0434      Map2k4          Mitogen-activated protein kinase kinase 4
  1373865_at                  1.3468        0.0436      Snap91          Synaptosomal-associated protein, 91 kda homolog (mouse)
  1382199_at                  1.3447        0.0327      Map1lc3b        Microtubule-associated protein 1 light chain 3 beta
  1387356_at                  1.3411        0.0333      Wfs1            Wolfram syndrome 1 (wolframin)
  1369653_at                  1.3385        0.0373      Tgfbr2          Transforming growth factor, beta receptor II (70/80 kDa)
  1371659_at                  1.3332        0.0472      Rhoc            Ras homolog gene family, member C
  1391390_at                  1.3288        0.0236      Tns1            Tensin 1
  1368006_at                  1.3273        0.0236      Laptm5          Lysosomal protein transmembrane 5
  1387654_at                  1.3194        0.0428      Myo1c           Myosin IC
  1393639_at                  1.3177        0.0441      Myo10           Myosin X
  1370097_a\_at               1.3168        0.0374      Cxcr4           Chemokine (C-X-C motif) receptor 4
  1395782_at                  1.3153        0.0421      Yeats4          YEATS domain containing 4
  1384186_at                  1.3133        0.0334      Edem1           ER degradation enhancer, mannosidase alpha-like 1
  1370087_at                  1.3130        0.0327      Rab2a           RAB2A, member RAS oncogene family
  1368953_at                  1.3126        0.0437      Uggt1           UDP-glucose glycoprotein glucosyltransferase 1
  1368490_at                  1.3119        0.0212      Cd14            CD14 molecule
  1392174_at                  1.2989        0.0270      Chst12          Carbohydrate (chondroitin 4) sulfotransferase 12
  1368932_at                  1.2889        0.0411      Rock1           Rho-associated, coiled-coil containing protein kinase 1
  1387521_at                  1.2804        0.0470      Pdcd4           Programmed cell death 4 (neoplastic transformation inhibitor)
  1380993_at                  1.2497        0.0412      Fam20b          Family with sequence similarity 20, member B
  1368655_at                  1.2456        0.0321      Srgn            Serglycin
  1387170_at                  1.2384        0.0473      Csnk2a1         Casein kinase 2, alpha 1 polypeptide
  1369404_a\_at               1.2274        0.0415      Nrxn1           Neurexin 1
  1373240_at                  1.2135        0.0381      Dhrs3           Dehydrogenase/reductase (SDR family) member 3
  1376795_at                  1.2133        0.0406      Pik3ap1         Phosphoinositide-3-kinase adaptor protein 1
  1385676_at                  1.2077        0.0434      Cd2bp2          CD2 (cytoplasmic tail) binding protein 2
  1371762_at                  −3.6666       0.0137      Rbp4            Retinol binding protein 4, plasma
  1376047_at                  −1.6495       0.0180      Papss2          3′-phosphoadenosine 5′-phosphosulfate synthase 2
  1385722_at                  −1.6489       0.0369      Sim2            Single-minded homolog 2 (*Drosophila*)
  1387843_at                  −1.5384       0.0180      Fst             Follistatin
  1368578_at                  −1.4838       0.0370      Hsd3b2          Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
  1372208_at                  −1.4789       0.0333      Ppp1r1b         Protein phosphatase 1, regulatory (inhibitor) subunit 1B
  1378632_at                  −1.4769       0.0303      Ppfia4          Protein tyrosine phosphatase, receptor type, interacting protein, alpha 4
  1384834_at                  −1.4525       0.0321      Cobl            Cordon-bleu homolog (mouse)
  1376175_at                  −1.4394       0.0371      Gbas            Glioblastoma amplified sequence
  1387599_a\_at               −1.4347       0.0175      Nqo1            NAD(P)H dehydrogenase, quinone 1
  1388721_at                  −1.4340       0.0306      Hspb8           Heat shock 22 kDa protein 8
  1377342_s\_at               −1.4313       0.0333      Fnbp1           Formin binding protein 1
  1376248_at                  −1.4056       0.0402      Sult2b1         Sulfotransferase family, cytosolic, 2B, member 1
  1368247_at                  −1.3986       0.0335      Hspa1a/hspa1b   Heat shock 70 kDa protein 1A
  1378069_at                  −1.3825       0.0259      Pkn1            Protein kinase N1
  1387234_at                  −1.3696       0.0321      Azgp1           Alpha-2-glycoprotein 1, zinc-binding
  1370385_at                  −1.3498       0.0268      Pla2g6          Phospholipase A2, group VI (cytosolic, calcium-independent)
  1388972_at                  −1.3494       0.0215      Rtn4r           Reticulon 4 receptor
  1367953_at                  −1.3473       0.0492      Tyro3           TYRO3 protein tyrosine kinase
  1372467_at                  −1.3411       0.0425      Hs6st1          Heparan sulfate 6-*O*-sulfotransferase 1
  1387898_at                  −1.3285       0.0234      Hspb6           Heat shock protein, alpha-crystallin-related, B6
  1397224_at                  −1.3272       0.0287      Atp2b1          ATPase, Ca++ transporting, plasma membrane 1
  1395499_at                  −1.3089       0.0335      Eps8            Epidermal growth factor receptor pathway substrate 8
  1372265_at                  −1.3030       0.0459      C14orf153       Chromosome 14 open reading frame 153
  1373494_at                  −1.2980       0.0259      Bcr             Breakpoint cluster region
  1379413_at                  −1.2966       0.0378      Nmnat1          Nicotinamide nucleotide adenylyltransferase 1
  1367812_at                  −1.2966       0.0334      Sptbn2          Spectrin, beta, non-erythrocytic 2
  1378198_at                  −1.2959       0.0333      Ophn1           Oligophrenin 1
  1367977_at                  −1.2942       0.0406      Snca            Synuclein, alpha (non-A4 component of amyloid precursor)
  1368774_a\_at               −1.2666       0.0399      Espn            Espin
  1372638_at                  −1.2656       0.0434      Arhgef7         Rho guanine nucleotide exchange factor (GEF) 7
  1368785_a\_at               −1.2595       0.0406      Pitx2           Paired-like homeodomain 2
  1382055_at                  −1.2588       0.0316      Rtkn            Rhotekin
  1387124_at                  −1.2526       0.0499      Inha            Inhibin, alpha
  1376041_at                  −1.2509       0.0321      Epn3            Epsin 3
  1396392_at                  −1.2474       0.0446      Dctn6           Dynactin 6
  1384319_at                  −1.2451       0.0436      Tlk2            Tousled-like kinase 2
  1373146_at                  −1.2379       0.0323      Ssx2ip          Synovial sarcoma, X breakpoint 2 interacting protein
  1374444_at                  −1.2367       0.0424      Plxnb1          Plexin B1
  1391915_at                  −1.2313       0.0411      Hspa9           Heat shock 70 kDa protein 9 (mortalin)
  1385526_at                  −1.2223       0.0441      Atg5            ATG5 autophagy related 5 homolog (*S. cerevisiae*)
  1381190_at                  −1.2181       0.0444      Lmo7            LIM domain 7
  1387656_at                  −1.2131       0.0463      Slc4a1          Solute carrier family 4, anion exchanger, member 1

Statistical analyses of the microarray data were performed with RMA, robust multiarray averaging; BH, Benjamini and Hochberg adjustment using the R statistical package (version 2.8.1). The complete microarray data is available to the reviewers at the following link: <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=hryjdweamuioidi&acc=GSE30770>
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